130 related articles for article (PubMed ID: 29756580)
1. Subtypes of Antiphospholipid Antibodies in Neurologic Disorders: An Observational Study.
Sahebari M; Rastin M; Boostani R; Forughipour M; Hashemzadeh K; Sadeghi SH
Curr Rheumatol Rev; 2019; 15(1):59-66. PubMed ID: 29756580
[TBL] [Abstract][Full Text] [Related]
2. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.
Hoxha A; Ruffatti A; Mattia E; Meneghel L; Tonello M; Salvan E; Pengo V; Punzi L
Clin Chem Lab Med; 2015 Jul; 53(8):1265-70. PubMed ID: 25562605
[TBL] [Abstract][Full Text] [Related]
3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic Primary Antiphospholipid Syndrome: the profile of antibody positivity in patients from North India.
Ahluwalia J; Sreedharanunni S; Kumar N; Masih J; Bose SK; Varma N; Varma S; Singh S
Int J Rheum Dis; 2016 Sep; 19(9):903-12. PubMed ID: 25292011
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
Samarkos M; Davies KA; Gordon C; Loizou S
Clin Rheumatol; 2006 Mar; 25(2):199-204. PubMed ID: 16091839
[TBL] [Abstract][Full Text] [Related]
6. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β
Nakamura H; Oku K; Amengual O; Ohmura K; Fujieda Y; Kato M; Bohgaki T; Yasuda S; Atsumi T
Arthritis Care Res (Hoboken); 2018 Apr; 70(4):627-634. PubMed ID: 28686816
[TBL] [Abstract][Full Text] [Related]
7. Isolated anti-β2-glycoprotein I antibodies in neurology: a frontier syndrome between multiple sclerosis and antiphospholipid syndrome?
Renaud M; Aupy J; Uring-Lambert B; Chanson JB; Collongues N; Blanc F; De Sèze J
Eur J Neurol; 2014 Jun; 21(6):901-6. PubMed ID: 24698178
[TBL] [Abstract][Full Text] [Related]
8. IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome.
Mattia E; Ruffatti A; Tonello M; Meneghel L; Robecchi B; Pittoni M; Gallo N; Salvan E; Teghil V; Punzi L; Plebani M
Clin Chem Lab Med; 2014 Sep; 52(9):1329-33. PubMed ID: 24651022
[TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid antibodies correlate with stroke severity and outcome in patients with antiphospholipid syndrome.
Rodríguez-Sanz A; Martínez-Sánchez P; Prefasi D; Fuentes B; Pascual-Salcedo D; Blanco-Bañares MJ; Díez-Tejedor E
Autoimmunity; 2015; 48(5):275-81. PubMed ID: 25434364
[TBL] [Abstract][Full Text] [Related]
10. Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.
Stojanovich L; Kontic M; Djokovic A; Marisavljevic D; Ilijevski N; Stanisavljevic N; Mikovic Z; Petkovic M; Kovcin V
Clin Exp Rheumatol; 2013; 31(2):234-42. PubMed ID: 23306109
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
12. Association between non-thrombotic neurological and cardiac manifestations in patients with antiphospholipid syndrome.
Stojanovich L; Kontic M; Smiljanic D; Djokovic A; Stamenkovic B; Marisavljevic D
Clin Exp Rheumatol; 2013; 31(5):756-60. PubMed ID: 23899875
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles.
Pengo V; Ruffatti A; Tonello M; Hoxha A; Bison E; Denas G; Padayattil Jose S; Zoppellaro G; Bracco A; Banzato A
Thromb Res; 2015 Jul; 136(1):161-3. PubMed ID: 25959581
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of anticardiolipin antibody in patients with systemic lupus erythematosus and its association with clinical manifestations.
Basiri Z; Gholyaf M; Faridnia M; Nadi E; Bairanvand M
Acta Med Iran; 2013; 51(1):35-40. PubMed ID: 23456582
[TBL] [Abstract][Full Text] [Related]
15. Associations of antiphospholipid antibodies with splanchnic vein thrombosis: a systematic review with meta-analysis.
Qi X; De Stefano V; Su C; Bai M; Guo X; Fan D
Medicine (Baltimore); 2015 Jan; 94(4):e496. PubMed ID: 25634200
[TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid antibodies in patients with purported 'chronic Lyme disease'.
Greco TP; Conti-Kelly AM; Greco TP
Lupus; 2011 Nov; 20(13):1372-7. PubMed ID: 21729977
[TBL] [Abstract][Full Text] [Related]
17. Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.
Parkpian V; Verasertniyom O; Vanichapuntu M; Totemchokchyakarn K; Nantiruj K; Pisitkul P; Angchaisuksiri P; Archararit N; Rachakom B; Ayurachai K; Janwityanujit S
Clin Rheumatol; 2007 Oct; 26(10):1663-70. PubMed ID: 17332980
[TBL] [Abstract][Full Text] [Related]
18. BF*F allotype of the alternative pathway of complement: A marker of protection against the development of antiphospholipid antibodies in patients with systemic lupus erythematosus.
Picceli VF; Skare TL; Nisihara RM; Nass FR; Messias-Reason IT; Utiyama SR
Lupus; 2016 Apr; 25(4):412-7. PubMed ID: 26537423
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of antiphospholipid antibodies in systemic sclerosis: A systematic review and meta-analysis.
Merashli M; Alves J; Ames PRJ
Semin Arthritis Rheum; 2017 Apr; 46(5):615-624. PubMed ID: 27838012
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of antiphospholipid antibody measured by EliA anticardiolipin antibodies and anti-β2Glycoprotein I antibodies in antiphospholipid syndrome].
Fujieda Y; Shida H; Oku K; Bohgaki T; Amengual O; Horita T; Yasuda S; Atsumi T
Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(5):430-6. PubMed ID: 25744643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]